Key result
Overweight status linked to ~51% lower NSTEMI mortality vs. normal weight.
Why the study?
The obesity paradox has been observed in cardiovascular disease, but whether obesity has a protective effect in patients presenting with NSTEMI remained to be evaluated.
Population
3,597,279 NSTEMI patients over the age of 18 years
Comparison
Mortality across weight categories (overweight, obesity, morbid obesity, normal weight, and cachexia)
Design
Retrospective database study using the Nationwide Inpatient Sample
Authors
Loading...
Caution against assuming protective obesity effect in NSTEMI; leaves open confounding and causality for prospective study.
Observational (n=3,597,279)
Yes
Odds Ratio: 0.49 (95% CI 0.41–0.59)
Absolute Event Rate: 3.2% vs 7.8%
p-value: p=<0.001
Hashemzadeh et al. (2025) conducted an observational in non-ST-elevation myocardial infarction (NSTEMI) (n=3,597,279). Overweight vs. Normal weight was evaluated on Mortality (OR 0.49, 95% CI 0.41-0.59, p=<0.001). In patients with NSTEMI, being overweight was associated with lower mortality compared to normal weight (3.2% vs 7.8%; OR 0.49, 95% CI 0.41-0.59, P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: